Vanda Pharmaceuticals | VNDA - Créances Commerciales





Créances Commerciales Changement Date
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 15.68M 203.19M 2026-03
AstraZeneca USD 17.88B 1.17B 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Eli Lilly USD 21.18B 1.02B 2026-03
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Halozyme Therapeutics USD 457.99M 16.72M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 178.55M 37.7M 2026-03
J&J USD 21.33B 3.72B 2025-12
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
Merck USD 11.78B 345M 2025-12
Moderna USD 71M 113M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Pfizer USD 16.17B 332M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Takeda JPY 876.35B 118.43B 2026-03
Teva Pharmaceutical Industries USD 3.39B 316M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Veracyte USD 50.11M 5.45M 2026-03